Takeda Pharmaceutical Company Limited (TKDA) - Total Liabilities

Latest as of December 2025: €7.76 Trillion EUR ≈ $9.08 Trillion USD

Based on the latest financial reports, Takeda Pharmaceutical Company Limited (TKDA) has total liabilities worth €7.76 Trillion EUR (≈ $9.08 Trillion USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Takeda Pharmaceutical Company Limited - Total Liabilities Trend (2017–2025)

This chart illustrates how Takeda Pharmaceutical Company Limited's total liabilities have evolved over time, based on quarterly financial data. See Takeda Pharmaceutical Company Limited (TKDA) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Takeda Pharmaceutical Company Limited Competitors by Total Liabilities

The table below lists competitors of Takeda Pharmaceutical Company Limited ranked by their total liabilities.

Company	Country	Total Liabilities
Jiangsu Hengrui Medicine Co Ltd SHG:600276	China	CN¥8.30 Billion
Itaú Unibanco Holding S.A. SA:ITUB3	Brazil	R$2.95 Trillion
East Money Information Co Ltd SHE:300059	China	CN¥344.29 Billion
CTBC Financial Holding Co Ltd TW:2891	Taiwan	NT$8.78 Trillion
Ambev S.A. F:AMNA	Germany	€56.31 Billion
LG Electronics Inc KO:066570	Korea	₩40.25 Trillion
Doosan Heavy Ind. & Const. KO:034020	Korea	₩15.50 Trillion
STANDARD CHART.UNSP.ADR/2 F:STD0	Germany	€918.22 Billion

Liability Composition Analysis (2017–2025)

This chart breaks down Takeda Pharmaceutical Company Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Takeda Pharmaceutical Company Limited (TKDA) market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	1.19	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.02	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.50	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Takeda Pharmaceutical Company Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Takeda Pharmaceutical Company Limited (2017–2025)

The table below shows the annual total liabilities of Takeda Pharmaceutical Company Limited from 2017 to 2025.

Year	Total Liabilities	Change
2025-03-31	€7.31 Trillion ≈ $8.55 Trillion	-6.67%
2024-03-31	€7.83 Trillion ≈ $9.16 Trillion	+3.05%
2023-03-31	€7.60 Trillion ≈ $8.89 Trillion	+1.45%
2022-03-31	€7.49 Trillion ≈ $8.76 Trillion	-3.11%
2021-03-31	€7.74 Trillion ≈ $9.04 Trillion	-4.43%
2020-03-31	€8.09 Trillion ≈ $9.46 Trillion	-7.06%
2019-03-31	€8.71 Trillion ≈ $10.18 Trillion	+316.87%
2018-03-31	€2.09 Trillion ≈ $2.44 Trillion	-13.20%
2017-03-31	€2.41 Trillion ≈ $2.81 Trillion	--

About Takeda Pharmaceutical Company Limited

F:TKDA Germany Drug Manufacturers - Specialty & Generic

Market Cap

$47.65 Billion

€40.75 Billion EUR

Market Cap Rank

#620 Global

#127 in Germany

Share Price

€12.90

Change (1 day)

-3.01%

52-Week Range

€11.30 - €16.10

All Time High

€16.10